Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche announces discontinuation of RG-6206 development in DMD

Nov. 11, 2019

Lyvgen initiates first-in-human study of LVGN-6051 in advanced or metastatic malignancy

Nov. 11, 2019

New phase IIa study investigates use of MTPS-9579A in asthma

Nov. 11, 2019

First-in-human comparison of LY-2775240 and apremilast in healthy volunteers

Nov. 11, 2019

FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions

Nov. 11, 2019

SUNFISH study of risdiplam in type 2 and 3 SMA meets primary endpoint

Nov. 11, 2019

NKTR-358 safe and well tolerated in first-in-human study

Nov. 11, 2019

Now, Sleeping Beauty is the fairest of them all

Nov. 11, 2019

Glecaprevir/pibrentasvir investigated in young children with chronic HCV infection

Nov. 11, 2019

Zelluna Immunotherapy presents novel compound, ZI-H04, as cancer immunotherapeutic

Nov. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...